Menu Search
Equities

OPKO Health Inc

OPK:NSQ

OPKO Health Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)1.62
  • Today's Change0.04 / 2.53%
  • Shares traded4.14m
  • 1 Year change+7.28%
  • Beta1.6309
Data delayed at least 15 minutes, as of Nov 25 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year OPKO Health Inc has grown net income from a loss of -328.41m to a smaller loss of -188.86m despite declining revenues.
Gross margin25.10%
Net profit margin-18.80%
Operating margin-26.42%
Return on assets-6.20%
Return on equity-9.39%
Return on investment-6.86%
More ▼

Cash flow in USDView more

In 2023, cash reserves at OPKO Health Inc fell by 57.31m. Cash Flow from Financing was negative, which signals that this company did not need to attract significant financing from outside sources. In addition the company used 28.20m for operations while cash used for investing totalled 18.20m.
Cash flow per share-0.0456
Price/Cash flow per share--
Book value per share2.06
Tangible book value per share0.0457
More ▼

Balance sheet in USDView more

OPKO Health Inc has a Debt to Total Capital ratio of 24.18%, a higher figure than the previous year's 15.84%.
Current ratio2.97
Quick ratio2.69
Total debt/total equity0.3189
Total debt/total capital0.2418
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.